Despite that exogenous BDNF therapy is not beneficial for ALS [124,167], BDNF and other neurotrophins are synthesized in response to myocyte activity to ameliorate NMJ activity. This evidence concerns the gene BDNF and amyotrophic lateral sclerosis.